Read + Share
Edwards CJ, Sette A, Cox C, Di Fiore B, et al. The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to
promote anti-tumour activity. Br J Cancer 2022;126:1168-1177.
PMID: 34969998
|
 |
|
Edwards CJ, Sette A, Cox C, Di Fiore B, et al. The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to
promote anti-tumour activity. Br J Cancer 2022;126:1168-1177.
PMID: 34969998
|
|
|
|